Review





Similar Products

99
ATCC a549 human lung carcinoma epithelial cells
A549 Human Lung Carcinoma Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/a549 human lung carcinoma epithelial cells/product/ATCC
Average 99 stars, based on 1 article reviews
a549 human lung carcinoma epithelial cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human epithelial lung carcinoma cells
Human Epithelial Lung Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human epithelial lung carcinoma cells/product/ATCC
Average 99 stars, based on 1 article reviews
human epithelial lung carcinoma cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC culture conditions human carcinoma lung epithelial cell line a549
Culture Conditions Human Carcinoma Lung Epithelial Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/culture conditions human carcinoma lung epithelial cell line a549/product/ATCC
Average 99 stars, based on 1 article reviews
culture conditions human carcinoma lung epithelial cell line a549 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human carcinoma lung epithelial cell line a549
Cell viability ( A ), LDH release ( B ), and caspase-1 activity ( C ) of the <t>A549</t> cells treated with phages vB_SauM-A, vB_SauM-C, vB_SauM-D, 1.0 mg/mL lactoferrin, 2.0 mg/mL linezolid, and bacteriophages supplemented with 1 mg/mL lactoferrin in comparison to the untreated negative control and positive control. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using one-way ANOVA, with *** p < 0.001
Human Carcinoma Lung Epithelial Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human carcinoma lung epithelial cell line a549/product/ATCC
Average 99 stars, based on 1 article reviews
human carcinoma lung epithelial cell line a549 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human lung epithelial carcinoma a549
Activation of RNase L after viral infection and effect of OAS3 on RNase L activation (A) <t>A549-ACE2</t> cells (rs10774671 A/A genotype) were infected (MOI 1), during 24 and 48 h. Total RNA was purified and analyzed in a Bioanalyzer. (B) Silencing OAS1 or OAS3 with siRNAs reduced the corresponding mRNA expression and attenuated RNA degradation induced by SARS-CoV-2 at 24h. two-way ANOVA and Sidak’s multiple comparison test, ∗∗ p = 0.002 for OAS1 mRNA and ∗ p = 0.010 for OAS3 mRNA (C) Viral load of silenced cells as assessed by measuring the viral titers in the cell culture supernatants using a lysis plaque formation assay. One-way ANOVA and Dunnett’s multiple comparisons test (∗ p = 0.024). (D) Cellular extracts from poly(I:C)-transfected cells were collected and subjected to Western blot analyses using an anti-OAS3 antibody and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (E and F) Parental A549-ACE2 and two clones of OAS3 KO cells were left mock-treated or treated with poly(I:C) (E), or either left mock-infected or infected with SARS-CoV-2 (MOI 1) (F). RNAs were purified and analyzed in a Bioanalyzer 24 hpt (E) or 24 and 48 hpi (F). (G) Viral titers in the cell culture supernatants of (F) were measured by a lysis plaque formation assay. two-way ANOVA and Tukey’s multiple comparison test, ∗∗ p = 0.002, ∗∗∗ p = 0.0003. (H) Cellular extracts from HEK293T-ACE2 mock-infected cells were collected and subjected to Western blot analyses using an anti-myc antibody (to detect OAS1-p42, OAS-p46 and OAS3, indicated by arrows) and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (I) HEK293T-ACE2 cells and (J) A549-ACE2 OAS3 KO cells were transfected with pCAGGS plasmids expressing the OAS1 WT, OAS3 WT, or with the empty plasmid, as control. At 24 hpt, the cells were infected with SARS-CoV-2 (MOI 1) for an additional 24 h and viral titers were measured. One-way ANOVA and Sidak’s multiple comparison test, symbols indicate comparison vs. ‘Empty’ (∗) or vs. ‘OAS1-p42’ ( & ). (I) OAS1-p42 ∗∗ p = 0.0065, OAS1-p46 ∗∗∗∗ p < 0.0001, OAS3 ∗∗∗ p = 0.0003; && p = 0.0076. (J) OAS1-p46 ∗∗ p = 0.0028, OAS3 ∗∗ p = 0.0016, & p = 0.0365. Data are represented as mean ± SD.
Human Lung Epithelial Carcinoma A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung epithelial carcinoma a549/product/ATCC
Average 99 stars, based on 1 article reviews
human lung epithelial carcinoma a549 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human lung carcinoma epithelial cells
Activation of RNase L after viral infection and effect of OAS3 on RNase L activation (A) <t>A549-ACE2</t> cells (rs10774671 A/A genotype) were infected (MOI 1), during 24 and 48 h. Total RNA was purified and analyzed in a Bioanalyzer. (B) Silencing OAS1 or OAS3 with siRNAs reduced the corresponding mRNA expression and attenuated RNA degradation induced by SARS-CoV-2 at 24h. two-way ANOVA and Sidak’s multiple comparison test, ∗∗ p = 0.002 for OAS1 mRNA and ∗ p = 0.010 for OAS3 mRNA (C) Viral load of silenced cells as assessed by measuring the viral titers in the cell culture supernatants using a lysis plaque formation assay. One-way ANOVA and Dunnett’s multiple comparisons test (∗ p = 0.024). (D) Cellular extracts from poly(I:C)-transfected cells were collected and subjected to Western blot analyses using an anti-OAS3 antibody and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (E and F) Parental A549-ACE2 and two clones of OAS3 KO cells were left mock-treated or treated with poly(I:C) (E), or either left mock-infected or infected with SARS-CoV-2 (MOI 1) (F). RNAs were purified and analyzed in a Bioanalyzer 24 hpt (E) or 24 and 48 hpi (F). (G) Viral titers in the cell culture supernatants of (F) were measured by a lysis plaque formation assay. two-way ANOVA and Tukey’s multiple comparison test, ∗∗ p = 0.002, ∗∗∗ p = 0.0003. (H) Cellular extracts from HEK293T-ACE2 mock-infected cells were collected and subjected to Western blot analyses using an anti-myc antibody (to detect OAS1-p42, OAS-p46 and OAS3, indicated by arrows) and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (I) HEK293T-ACE2 cells and (J) A549-ACE2 OAS3 KO cells were transfected with pCAGGS plasmids expressing the OAS1 WT, OAS3 WT, or with the empty plasmid, as control. At 24 hpt, the cells were infected with SARS-CoV-2 (MOI 1) for an additional 24 h and viral titers were measured. One-way ANOVA and Sidak’s multiple comparison test, symbols indicate comparison vs. ‘Empty’ (∗) or vs. ‘OAS1-p42’ ( & ). (I) OAS1-p42 ∗∗ p = 0.0065, OAS1-p46 ∗∗∗∗ p < 0.0001, OAS3 ∗∗∗ p = 0.0003; && p = 0.0076. (J) OAS1-p46 ∗∗ p = 0.0028, OAS3 ∗∗ p = 0.0016, & p = 0.0365. Data are represented as mean ± SD.
Human Lung Carcinoma Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung carcinoma epithelial cells/product/ATCC
Average 99 stars, based on 1 article reviews
human lung carcinoma epithelial cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human 759 lung carcinoma epithelial cells
Activation of RNase L after viral infection and effect of OAS3 on RNase L activation (A) <t>A549-ACE2</t> cells (rs10774671 A/A genotype) were infected (MOI 1), during 24 and 48 h. Total RNA was purified and analyzed in a Bioanalyzer. (B) Silencing OAS1 or OAS3 with siRNAs reduced the corresponding mRNA expression and attenuated RNA degradation induced by SARS-CoV-2 at 24h. two-way ANOVA and Sidak’s multiple comparison test, ∗∗ p = 0.002 for OAS1 mRNA and ∗ p = 0.010 for OAS3 mRNA (C) Viral load of silenced cells as assessed by measuring the viral titers in the cell culture supernatants using a lysis plaque formation assay. One-way ANOVA and Dunnett’s multiple comparisons test (∗ p = 0.024). (D) Cellular extracts from poly(I:C)-transfected cells were collected and subjected to Western blot analyses using an anti-OAS3 antibody and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (E and F) Parental A549-ACE2 and two clones of OAS3 KO cells were left mock-treated or treated with poly(I:C) (E), or either left mock-infected or infected with SARS-CoV-2 (MOI 1) (F). RNAs were purified and analyzed in a Bioanalyzer 24 hpt (E) or 24 and 48 hpi (F). (G) Viral titers in the cell culture supernatants of (F) were measured by a lysis plaque formation assay. two-way ANOVA and Tukey’s multiple comparison test, ∗∗ p = 0.002, ∗∗∗ p = 0.0003. (H) Cellular extracts from HEK293T-ACE2 mock-infected cells were collected and subjected to Western blot analyses using an anti-myc antibody (to detect OAS1-p42, OAS-p46 and OAS3, indicated by arrows) and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (I) HEK293T-ACE2 cells and (J) A549-ACE2 OAS3 KO cells were transfected with pCAGGS plasmids expressing the OAS1 WT, OAS3 WT, or with the empty plasmid, as control. At 24 hpt, the cells were infected with SARS-CoV-2 (MOI 1) for an additional 24 h and viral titers were measured. One-way ANOVA and Sidak’s multiple comparison test, symbols indicate comparison vs. ‘Empty’ (∗) or vs. ‘OAS1-p42’ ( & ). (I) OAS1-p42 ∗∗ p = 0.0065, OAS1-p46 ∗∗∗∗ p < 0.0001, OAS3 ∗∗∗ p = 0.0003; && p = 0.0076. (J) OAS1-p46 ∗∗ p = 0.0028, OAS3 ∗∗ p = 0.0016, & p = 0.0365. Data are represented as mean ± SD.
Human 759 Lung Carcinoma Epithelial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human 759 lung carcinoma epithelial cells/product/ATCC
Average 99 stars, based on 1 article reviews
human 759 lung carcinoma epithelial cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human lung carcinoma epithelial cell line a549
Activation of RNase L after viral infection and effect of OAS3 on RNase L activation (A) <t>A549-ACE2</t> cells (rs10774671 A/A genotype) were infected (MOI 1), during 24 and 48 h. Total RNA was purified and analyzed in a Bioanalyzer. (B) Silencing OAS1 or OAS3 with siRNAs reduced the corresponding mRNA expression and attenuated RNA degradation induced by SARS-CoV-2 at 24h. two-way ANOVA and Sidak’s multiple comparison test, ∗∗ p = 0.002 for OAS1 mRNA and ∗ p = 0.010 for OAS3 mRNA (C) Viral load of silenced cells as assessed by measuring the viral titers in the cell culture supernatants using a lysis plaque formation assay. One-way ANOVA and Dunnett’s multiple comparisons test (∗ p = 0.024). (D) Cellular extracts from poly(I:C)-transfected cells were collected and subjected to Western blot analyses using an anti-OAS3 antibody and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (E and F) Parental A549-ACE2 and two clones of OAS3 KO cells were left mock-treated or treated with poly(I:C) (E), or either left mock-infected or infected with SARS-CoV-2 (MOI 1) (F). RNAs were purified and analyzed in a Bioanalyzer 24 hpt (E) or 24 and 48 hpi (F). (G) Viral titers in the cell culture supernatants of (F) were measured by a lysis plaque formation assay. two-way ANOVA and Tukey’s multiple comparison test, ∗∗ p = 0.002, ∗∗∗ p = 0.0003. (H) Cellular extracts from HEK293T-ACE2 mock-infected cells were collected and subjected to Western blot analyses using an anti-myc antibody (to detect OAS1-p42, OAS-p46 and OAS3, indicated by arrows) and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (I) HEK293T-ACE2 cells and (J) A549-ACE2 OAS3 KO cells were transfected with pCAGGS plasmids expressing the OAS1 WT, OAS3 WT, or with the empty plasmid, as control. At 24 hpt, the cells were infected with SARS-CoV-2 (MOI 1) for an additional 24 h and viral titers were measured. One-way ANOVA and Sidak’s multiple comparison test, symbols indicate comparison vs. ‘Empty’ (∗) or vs. ‘OAS1-p42’ ( & ). (I) OAS1-p42 ∗∗ p = 0.0065, OAS1-p46 ∗∗∗∗ p < 0.0001, OAS3 ∗∗∗ p = 0.0003; && p = 0.0076. (J) OAS1-p46 ∗∗ p = 0.0028, OAS3 ∗∗ p = 0.0016, & p = 0.0365. Data are represented as mean ± SD.
Human Lung Carcinoma Epithelial Cell Line A549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung carcinoma epithelial cell line a549/product/ATCC
Average 99 stars, based on 1 article reviews
human lung carcinoma epithelial cell line a549 - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

99
ATCC human lung epithelial carcinoma cell line a549 cells
Activation of RNase L after viral infection and effect of OAS3 on RNase L activation (A) <t>A549-ACE2</t> cells (rs10774671 A/A genotype) were infected (MOI 1), during 24 and 48 h. Total RNA was purified and analyzed in a Bioanalyzer. (B) Silencing OAS1 or OAS3 with siRNAs reduced the corresponding mRNA expression and attenuated RNA degradation induced by SARS-CoV-2 at 24h. two-way ANOVA and Sidak’s multiple comparison test, ∗∗ p = 0.002 for OAS1 mRNA and ∗ p = 0.010 for OAS3 mRNA (C) Viral load of silenced cells as assessed by measuring the viral titers in the cell culture supernatants using a lysis plaque formation assay. One-way ANOVA and Dunnett’s multiple comparisons test (∗ p = 0.024). (D) Cellular extracts from poly(I:C)-transfected cells were collected and subjected to Western blot analyses using an anti-OAS3 antibody and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (E and F) Parental A549-ACE2 and two clones of OAS3 KO cells were left mock-treated or treated with poly(I:C) (E), or either left mock-infected or infected with SARS-CoV-2 (MOI 1) (F). RNAs were purified and analyzed in a Bioanalyzer 24 hpt (E) or 24 and 48 hpi (F). (G) Viral titers in the cell culture supernatants of (F) were measured by a lysis plaque formation assay. two-way ANOVA and Tukey’s multiple comparison test, ∗∗ p = 0.002, ∗∗∗ p = 0.0003. (H) Cellular extracts from HEK293T-ACE2 mock-infected cells were collected and subjected to Western blot analyses using an anti-myc antibody (to detect OAS1-p42, OAS-p46 and OAS3, indicated by arrows) and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (I) HEK293T-ACE2 cells and (J) A549-ACE2 OAS3 KO cells were transfected with pCAGGS plasmids expressing the OAS1 WT, OAS3 WT, or with the empty plasmid, as control. At 24 hpt, the cells were infected with SARS-CoV-2 (MOI 1) for an additional 24 h and viral titers were measured. One-way ANOVA and Sidak’s multiple comparison test, symbols indicate comparison vs. ‘Empty’ (∗) or vs. ‘OAS1-p42’ ( & ). (I) OAS1-p42 ∗∗ p = 0.0065, OAS1-p46 ∗∗∗∗ p < 0.0001, OAS3 ∗∗∗ p = 0.0003; && p = 0.0076. (J) OAS1-p46 ∗∗ p = 0.0028, OAS3 ∗∗ p = 0.0016, & p = 0.0365. Data are represented as mean ± SD.
Human Lung Epithelial Carcinoma Cell Line A549 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human lung epithelial carcinoma cell line a549 cells/product/ATCC
Average 99 stars, based on 1 article reviews
human lung epithelial carcinoma cell line a549 cells - by Bioz Stars, 2026-02
99/100 stars
  Buy from Supplier

Image Search Results


Cell viability ( A ), LDH release ( B ), and caspase-1 activity ( C ) of the A549 cells treated with phages vB_SauM-A, vB_SauM-C, vB_SauM-D, 1.0 mg/mL lactoferrin, 2.0 mg/mL linezolid, and bacteriophages supplemented with 1 mg/mL lactoferrin in comparison to the untreated negative control and positive control. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using one-way ANOVA, with *** p < 0.001

Journal: Applied Microbiology and Biotechnology

Article Title: Addition of lactoferrin increases efficacy of three Kayviruses and limits the inflammatory response in pulmonary epithelial cells

doi: 10.1007/s00253-025-13695-9

Figure Lengend Snippet: Cell viability ( A ), LDH release ( B ), and caspase-1 activity ( C ) of the A549 cells treated with phages vB_SauM-A, vB_SauM-C, vB_SauM-D, 1.0 mg/mL lactoferrin, 2.0 mg/mL linezolid, and bacteriophages supplemented with 1 mg/mL lactoferrin in comparison to the untreated negative control and positive control. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using one-way ANOVA, with *** p < 0.001

Article Snippet: Human carcinoma lung epithelial cell line A549 (ATCC, CCL-185) (ATCC, Manassas, VA, USA) were cultured in 75-cm 2 Culture Flask (Corning, New York, NY, USA) in a F-12 K culture medium (ATCC, Manassas, VA, USA) supplemented with 10% fetal bovine serum (FBS; ATCC, Manassas, VA, USA), at 37 °C in a humidified atmosphere of 95% air and 5% CO 2 in the HeraCell 150 incubator (Heraeus, Hanau, Germany) in accordance with the supplier’s guidelines.

Techniques: Activity Assay, Comparison, Negative Control, Positive Control

The CFU/mL of MRSA strains 70 ( A ), 110 ( B ), and 203 ( C ) in infected A549 cell line after treatment with phages vB_SauM-A, vB_SauM-C, and vB_SauM-D, lactoferrin, linezolid, or phage + Lf combination after 3 h and 6 h post-treatment. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using the Kruskal–Wallis test followed by Dunn’s multiple comparison test for values with nonparametric distribution, with *** p < 0.001

Journal: Applied Microbiology and Biotechnology

Article Title: Addition of lactoferrin increases efficacy of three Kayviruses and limits the inflammatory response in pulmonary epithelial cells

doi: 10.1007/s00253-025-13695-9

Figure Lengend Snippet: The CFU/mL of MRSA strains 70 ( A ), 110 ( B ), and 203 ( C ) in infected A549 cell line after treatment with phages vB_SauM-A, vB_SauM-C, and vB_SauM-D, lactoferrin, linezolid, or phage + Lf combination after 3 h and 6 h post-treatment. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using the Kruskal–Wallis test followed by Dunn’s multiple comparison test for values with nonparametric distribution, with *** p < 0.001

Article Snippet: Human carcinoma lung epithelial cell line A549 (ATCC, CCL-185) (ATCC, Manassas, VA, USA) were cultured in 75-cm 2 Culture Flask (Corning, New York, NY, USA) in a F-12 K culture medium (ATCC, Manassas, VA, USA) supplemented with 10% fetal bovine serum (FBS; ATCC, Manassas, VA, USA), at 37 °C in a humidified atmosphere of 95% air and 5% CO 2 in the HeraCell 150 incubator (Heraeus, Hanau, Germany) in accordance with the supplier’s guidelines.

Techniques: Infection, Comparison

Cell viability ( A , B , C ) and LDH release ( D , E , F ) from the infected A549 cells treated with phages vB_SauM-A, vB_SauM-C, vB_SauM-D, 1.0 mg/mL lactoferrin, 2.0 mg/mL linezolid, and phage + Lf combination in comparison to the untreated negative control and positive control. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using one-way ANOVA, with *** p < 0.001, ** p < 0.01, and * p < 0.05

Journal: Applied Microbiology and Biotechnology

Article Title: Addition of lactoferrin increases efficacy of three Kayviruses and limits the inflammatory response in pulmonary epithelial cells

doi: 10.1007/s00253-025-13695-9

Figure Lengend Snippet: Cell viability ( A , B , C ) and LDH release ( D , E , F ) from the infected A549 cells treated with phages vB_SauM-A, vB_SauM-C, vB_SauM-D, 1.0 mg/mL lactoferrin, 2.0 mg/mL linezolid, and phage + Lf combination in comparison to the untreated negative control and positive control. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using one-way ANOVA, with *** p < 0.001, ** p < 0.01, and * p < 0.05

Article Snippet: Human carcinoma lung epithelial cell line A549 (ATCC, CCL-185) (ATCC, Manassas, VA, USA) were cultured in 75-cm 2 Culture Flask (Corning, New York, NY, USA) in a F-12 K culture medium (ATCC, Manassas, VA, USA) supplemented with 10% fetal bovine serum (FBS; ATCC, Manassas, VA, USA), at 37 °C in a humidified atmosphere of 95% air and 5% CO 2 in the HeraCell 150 incubator (Heraeus, Hanau, Germany) in accordance with the supplier’s guidelines.

Techniques: Infection, Comparison, Negative Control, Positive Control

Inflammasome activation measured by caspase-1 activity in the infected A549 cells treated with phages vB_SauM-A, vB_SauM-C, vB_SauM-D, 1.0 mg/mL lactoferrin, 2.0 mg/mL linezolid, and phage + Lf combination in comparison to the untreated negative control and positive control. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using the Kruskal–Wallis test followed by Dunn’s multiple comparison test for values with nonparametric distribution, with *** p < 0.001

Journal: Applied Microbiology and Biotechnology

Article Title: Addition of lactoferrin increases efficacy of three Kayviruses and limits the inflammatory response in pulmonary epithelial cells

doi: 10.1007/s00253-025-13695-9

Figure Lengend Snippet: Inflammasome activation measured by caspase-1 activity in the infected A549 cells treated with phages vB_SauM-A, vB_SauM-C, vB_SauM-D, 1.0 mg/mL lactoferrin, 2.0 mg/mL linezolid, and phage + Lf combination in comparison to the untreated negative control and positive control. Arithmetic mean of triplicates with error bars representing SD. Statistical analysis was performed using the Kruskal–Wallis test followed by Dunn’s multiple comparison test for values with nonparametric distribution, with *** p < 0.001

Article Snippet: Human carcinoma lung epithelial cell line A549 (ATCC, CCL-185) (ATCC, Manassas, VA, USA) were cultured in 75-cm 2 Culture Flask (Corning, New York, NY, USA) in a F-12 K culture medium (ATCC, Manassas, VA, USA) supplemented with 10% fetal bovine serum (FBS; ATCC, Manassas, VA, USA), at 37 °C in a humidified atmosphere of 95% air and 5% CO 2 in the HeraCell 150 incubator (Heraeus, Hanau, Germany) in accordance with the supplier’s guidelines.

Techniques: Activation Assay, Activity Assay, Infection, Comparison, Negative Control, Positive Control

Activation of RNase L after viral infection and effect of OAS3 on RNase L activation (A) A549-ACE2 cells (rs10774671 A/A genotype) were infected (MOI 1), during 24 and 48 h. Total RNA was purified and analyzed in a Bioanalyzer. (B) Silencing OAS1 or OAS3 with siRNAs reduced the corresponding mRNA expression and attenuated RNA degradation induced by SARS-CoV-2 at 24h. two-way ANOVA and Sidak’s multiple comparison test, ∗∗ p = 0.002 for OAS1 mRNA and ∗ p = 0.010 for OAS3 mRNA (C) Viral load of silenced cells as assessed by measuring the viral titers in the cell culture supernatants using a lysis plaque formation assay. One-way ANOVA and Dunnett’s multiple comparisons test (∗ p = 0.024). (D) Cellular extracts from poly(I:C)-transfected cells were collected and subjected to Western blot analyses using an anti-OAS3 antibody and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (E and F) Parental A549-ACE2 and two clones of OAS3 KO cells were left mock-treated or treated with poly(I:C) (E), or either left mock-infected or infected with SARS-CoV-2 (MOI 1) (F). RNAs were purified and analyzed in a Bioanalyzer 24 hpt (E) or 24 and 48 hpi (F). (G) Viral titers in the cell culture supernatants of (F) were measured by a lysis plaque formation assay. two-way ANOVA and Tukey’s multiple comparison test, ∗∗ p = 0.002, ∗∗∗ p = 0.0003. (H) Cellular extracts from HEK293T-ACE2 mock-infected cells were collected and subjected to Western blot analyses using an anti-myc antibody (to detect OAS1-p42, OAS-p46 and OAS3, indicated by arrows) and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (I) HEK293T-ACE2 cells and (J) A549-ACE2 OAS3 KO cells were transfected with pCAGGS plasmids expressing the OAS1 WT, OAS3 WT, or with the empty plasmid, as control. At 24 hpt, the cells were infected with SARS-CoV-2 (MOI 1) for an additional 24 h and viral titers were measured. One-way ANOVA and Sidak’s multiple comparison test, symbols indicate comparison vs. ‘Empty’ (∗) or vs. ‘OAS1-p42’ ( & ). (I) OAS1-p42 ∗∗ p = 0.0065, OAS1-p46 ∗∗∗∗ p < 0.0001, OAS3 ∗∗∗ p = 0.0003; && p = 0.0076. (J) OAS1-p46 ∗∗ p = 0.0028, OAS3 ∗∗ p = 0.0016, & p = 0.0365. Data are represented as mean ± SD.

Journal: iScience

Article Title: OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2

doi: 10.1016/j.isci.2025.113966

Figure Lengend Snippet: Activation of RNase L after viral infection and effect of OAS3 on RNase L activation (A) A549-ACE2 cells (rs10774671 A/A genotype) were infected (MOI 1), during 24 and 48 h. Total RNA was purified and analyzed in a Bioanalyzer. (B) Silencing OAS1 or OAS3 with siRNAs reduced the corresponding mRNA expression and attenuated RNA degradation induced by SARS-CoV-2 at 24h. two-way ANOVA and Sidak’s multiple comparison test, ∗∗ p = 0.002 for OAS1 mRNA and ∗ p = 0.010 for OAS3 mRNA (C) Viral load of silenced cells as assessed by measuring the viral titers in the cell culture supernatants using a lysis plaque formation assay. One-way ANOVA and Dunnett’s multiple comparisons test (∗ p = 0.024). (D) Cellular extracts from poly(I:C)-transfected cells were collected and subjected to Western blot analyses using an anti-OAS3 antibody and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (E and F) Parental A549-ACE2 and two clones of OAS3 KO cells were left mock-treated or treated with poly(I:C) (E), or either left mock-infected or infected with SARS-CoV-2 (MOI 1) (F). RNAs were purified and analyzed in a Bioanalyzer 24 hpt (E) or 24 and 48 hpi (F). (G) Viral titers in the cell culture supernatants of (F) were measured by a lysis plaque formation assay. two-way ANOVA and Tukey’s multiple comparison test, ∗∗ p = 0.002, ∗∗∗ p = 0.0003. (H) Cellular extracts from HEK293T-ACE2 mock-infected cells were collected and subjected to Western blot analyses using an anti-myc antibody (to detect OAS1-p42, OAS-p46 and OAS3, indicated by arrows) and an anti-actin antibody. Molecular weight markers are indicated (in kDa) on the right. (I) HEK293T-ACE2 cells and (J) A549-ACE2 OAS3 KO cells were transfected with pCAGGS plasmids expressing the OAS1 WT, OAS3 WT, or with the empty plasmid, as control. At 24 hpt, the cells were infected with SARS-CoV-2 (MOI 1) for an additional 24 h and viral titers were measured. One-way ANOVA and Sidak’s multiple comparison test, symbols indicate comparison vs. ‘Empty’ (∗) or vs. ‘OAS1-p42’ ( & ). (I) OAS1-p42 ∗∗ p = 0.0065, OAS1-p46 ∗∗∗∗ p < 0.0001, OAS3 ∗∗∗ p = 0.0003; && p = 0.0076. (J) OAS1-p46 ∗∗ p = 0.0028, OAS3 ∗∗ p = 0.0016, & p = 0.0365. Data are represented as mean ± SD.

Article Snippet: Human lung epithelial carcinoma A549 (ATCC CCL-185, derived from lung carcinomatous tissue from a 58-year-old Caucassian male), human embryonic kidney HEK293T (ATCC CRL-11268, derived from a fetus), Vero E6 and Vero cells overexpressing the TMPRSS2 (Vero-TMPRSS2, kindly provided by Prof. Luis Enjuanes, CNB-CSIC, derived from the kidney of a normal adult African Green monkey) cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; Mediatech, Inc.) containing 10% fetal bovine serum (FBS) and 2 mM L-glutamine at 37°C in a 5% CO 2 incubator.

Techniques: Activation Assay, Infection, Purification, Expressing, Comparison, Cell Culture, Lysis, Plaque Formation Assay, Transfection, Western Blot, Molecular Weight, Clone Assay, Plasmid Preparation, Control

Effect of OAS1 and OAS3 expression on the induction of innate immune responses (A) A549-ACE2 cells (expressing OAS1-p42) were transfected twice with siRNAs specific for OAS1 or OAS3 or with a non-targeted (NT) siRNA. At 24 hpt, the cells were transfected with poly(I:C). Total RNA was purified 24h later for RT-qPCR measurement of the indicated inflammatory mediators. One-way ANOVA and Sidak’s multiple comparison test vs. NT, IFNL1: ∗∗ p = 0.0038; TNF: ∗∗ p = 0.0025, ∗∗∗ p < 0.0001; CXCL10: ∗ p = 0.0306). (B) Parental cells and two clones of OAS3 KO cells were transfected with two different concentrations of poly(I:C) (low: 50 ng/mL and high: 250 ng/mL) or none. At 24h, total RNA was purified for RT-qPCR measurement of the indicated inflammatory mediators. two-way ANOVA and Tukey’s multiple comparison test vs. WT, IFNL1: low ∗∗ p = 0.0084, high ∗∗ p = 0.0066, ∗∗∗+ p < 0.0001; TNF: ∗∗ p = 0.0062, ∗∗∗∗ p < 0.0001; CXCL10: ∗∗ p = 0.001; ∗∗∗ p = 0.0007. (C) A549-ACE2 cells were transfected twice with siRNAs specific for OAS1 or OAS3 or with a non-targeted (NT) siRNA and were treated with SARS-CoV-2. Inflammatory cytokine mRNA was determined at 24 hpi. One-way ANOVA and Sidak’s multiple comparison test vs. NT, IFNL1: ∗ p = 0.0463; TNF: ∗ p = 0.0298. (D) OAS3 KO A549-ACE2 cells were transfected with pCAGGS plasmids expressing the OAS1 WT (G/G allele encoding p46) or OAS3 WT forms, or with the empty plasmid, as control. At 24 hpt, the cells were transfected with poly(I:C) and total RNA was purified 24h later. The expression levels of IFNL1, TNF, CCL2, and CXCL10 mRNA were evaluated by RT-qPCR and are expressed as fold change in comparison to cells not exposed to poly(I:C). r.u.: relative units. One-way ANOVA and Sidak’s multiple comparison test vs. Empty, IFNL1: ∗ p = 0.0242; TNF:∗ p = 0.0289; CCL2: ∗∗ p = 0.0019, ∗∗∗ p = 0.0008; CXCL10: ∗ p = 0.0322 for PAS1p46, ∗ p = 0.0403 for OAS3. See also . (E) HEK293T-ACE2 cells were transfected with an empty plasmid, as control, or with plasmids expressing OAS1 rs10774671 (G/G) common genotype either WT or containing rare LOF variant genes. At 24 hpt, the cells were left mock-transfected as controls or transfected with poly(I:C); Total RNA was purified 24 h after poly(I:C) transfection and was analyzed; n = 4 samples obtained in two independent experiments. Values were compared vs. control (∗∗) or vs. WT (&) with one-way ANOVA and Sidak’s multiple comparison tests. IFNL1: ∗∗ p = 0.0026, & p = 0.0215 & p = 0.0215 for K206Q and & p = 0.0296 for R256W. TNF: ∗∗∗∗ p < 0.0001; ∗∗∗ p = 0.0006 for K206Q, ∗∗∗ p = 0.0003 for R256W; & p = 0.0248. Data are represented as mean ± SD.

Journal: iScience

Article Title: OAS1 and OAS3 genetic variants enhance inflammatory responses to SARS-CoV-2

doi: 10.1016/j.isci.2025.113966

Figure Lengend Snippet: Effect of OAS1 and OAS3 expression on the induction of innate immune responses (A) A549-ACE2 cells (expressing OAS1-p42) were transfected twice with siRNAs specific for OAS1 or OAS3 or with a non-targeted (NT) siRNA. At 24 hpt, the cells were transfected with poly(I:C). Total RNA was purified 24h later for RT-qPCR measurement of the indicated inflammatory mediators. One-way ANOVA and Sidak’s multiple comparison test vs. NT, IFNL1: ∗∗ p = 0.0038; TNF: ∗∗ p = 0.0025, ∗∗∗ p < 0.0001; CXCL10: ∗ p = 0.0306). (B) Parental cells and two clones of OAS3 KO cells were transfected with two different concentrations of poly(I:C) (low: 50 ng/mL and high: 250 ng/mL) or none. At 24h, total RNA was purified for RT-qPCR measurement of the indicated inflammatory mediators. two-way ANOVA and Tukey’s multiple comparison test vs. WT, IFNL1: low ∗∗ p = 0.0084, high ∗∗ p = 0.0066, ∗∗∗+ p < 0.0001; TNF: ∗∗ p = 0.0062, ∗∗∗∗ p < 0.0001; CXCL10: ∗∗ p = 0.001; ∗∗∗ p = 0.0007. (C) A549-ACE2 cells were transfected twice with siRNAs specific for OAS1 or OAS3 or with a non-targeted (NT) siRNA and were treated with SARS-CoV-2. Inflammatory cytokine mRNA was determined at 24 hpi. One-way ANOVA and Sidak’s multiple comparison test vs. NT, IFNL1: ∗ p = 0.0463; TNF: ∗ p = 0.0298. (D) OAS3 KO A549-ACE2 cells were transfected with pCAGGS plasmids expressing the OAS1 WT (G/G allele encoding p46) or OAS3 WT forms, or with the empty plasmid, as control. At 24 hpt, the cells were transfected with poly(I:C) and total RNA was purified 24h later. The expression levels of IFNL1, TNF, CCL2, and CXCL10 mRNA were evaluated by RT-qPCR and are expressed as fold change in comparison to cells not exposed to poly(I:C). r.u.: relative units. One-way ANOVA and Sidak’s multiple comparison test vs. Empty, IFNL1: ∗ p = 0.0242; TNF:∗ p = 0.0289; CCL2: ∗∗ p = 0.0019, ∗∗∗ p = 0.0008; CXCL10: ∗ p = 0.0322 for PAS1p46, ∗ p = 0.0403 for OAS3. See also . (E) HEK293T-ACE2 cells were transfected with an empty plasmid, as control, or with plasmids expressing OAS1 rs10774671 (G/G) common genotype either WT or containing rare LOF variant genes. At 24 hpt, the cells were left mock-transfected as controls or transfected with poly(I:C); Total RNA was purified 24 h after poly(I:C) transfection and was analyzed; n = 4 samples obtained in two independent experiments. Values were compared vs. control (∗∗) or vs. WT (&) with one-way ANOVA and Sidak’s multiple comparison tests. IFNL1: ∗∗ p = 0.0026, & p = 0.0215 & p = 0.0215 for K206Q and & p = 0.0296 for R256W. TNF: ∗∗∗∗ p < 0.0001; ∗∗∗ p = 0.0006 for K206Q, ∗∗∗ p = 0.0003 for R256W; & p = 0.0248. Data are represented as mean ± SD.

Article Snippet: Human lung epithelial carcinoma A549 (ATCC CCL-185, derived from lung carcinomatous tissue from a 58-year-old Caucassian male), human embryonic kidney HEK293T (ATCC CRL-11268, derived from a fetus), Vero E6 and Vero cells overexpressing the TMPRSS2 (Vero-TMPRSS2, kindly provided by Prof. Luis Enjuanes, CNB-CSIC, derived from the kidney of a normal adult African Green monkey) cells were grown in Dulbecco’s modified Eagle’s medium (DMEM; Mediatech, Inc.) containing 10% fetal bovine serum (FBS) and 2 mM L-glutamine at 37°C in a 5% CO 2 incubator.

Techniques: Expressing, Transfection, Purification, Quantitative RT-PCR, Comparison, Clone Assay, Plasmid Preparation, Control, Variant Assay